RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+16.76%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$6.22B
AUM Growth
+$6.22B
(+11%)
Cap. Flow
-$50.6M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
59.86%
Holding
75
New
7
Increased
28
Reduced
21
Closed
9
Top Buys
| 1 |
Fluor
FLR
|
$205M |
| 2 |
Viatris
VTRS
|
$107M |
| 3 |
Vistra
VST
|
$92.8M |
| 4 |
FTAI Aviation
FTAI
|
$86.2M |
| 5 |
PG&E
PCG
|
$50.2M |
Top Sells
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$471M |
| 2 |
Mr. Cooper
COOP
|
$87.1M |
| 3 |
Adaptive Biotechnologies
ADPT
|
$79.9M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$74.7M |
| 5 |
Dole
DOLE
|
$60M |
Sector Composition
| 1 | Healthcare | 34.28% |
| 2 | Utilities | 30.97% |
| 3 | Industrials | 11.68% |
| 4 | Energy | 8.3% |
| 5 | Financials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.31B | 19.79% | 4,505,302 -1,618,198 | -26% | -$471M |
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $436M | 6.58% | 26,000,000 +450,000 | +2% | +$7.54M |
|
|
3
FTAI Aviation
FTAI
$15.8B
| $390M | 5.9% | 3,394,080 +749,080 | +28% | +$86.2M |
|
4
Golar LNG
GLNG
$4.48B
| $378M | 5.71% | 9,178,978 +203,829 | +2% | +$8.4M |
|
|
5
Vistra
VST
$64.1B
| $276M | 4.17% | 1,424,803 +478,834 | +51% | +$92.8M |
|
6
Roivant Sciences
ROIV
$8.15B
| $230M | 3.47% | 20,370,336 +2,603,260 | +15% | +$29.3M |
|
|
7
Fluor
FLR
$6.63B
| $205M | 3.1% | +4,000,000 | New | +$205M |
|
8
BGC Group
BGC
$4.65B
| $174M | 2.63% | 17,005,582 -220,798 | -1% | -$2.26M |
|
9
TransAlta
TAC
$3.65B
| $172M | 2.6% | 15,948,451 +3,948,451 | +33% | +$42.6M |
|
10
Arcutis Biotherapeutics
ARQT
$1.86B
| $151M | 2.28% | 10,749,457 -217,215 | -2% | -$3.05M |
|
11
Mercury Insurance
MCY
$4.28B
| $138M | 2.09% | 2,054,504 +232,721 | +13% | +$15.7M |
|
12
QuidelOrtho
QDEL
$1.95B
| $134M | 2.02% | 4,637,738 -1,502,262 | -24% | -$43.3M |
|
13
Alight
ALIT
$2.05B
| $111M | 1.68% | 19,626,953 +1,906,140 | +11% | +$10.8M |
|
14
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $108M | 1.63% | 3,909,806 +526,567 | +16% | +$14.6M |
|
|
15
Viatris
VTRS
$12.3B
| $107M | 1.62% | +12,000,000 | New | +$107M |
|
16
Schrodinger
SDGR
$1.44B
| $101M | 1.52% | 5,000,000 +200,000 | +4% | +$4.02M |
|
17
ReNew
RNW
$2.76B
| $99.8M | 1.51% | 14,438,061 -89,351 | -0.6% | -$617K |
|
18
Amneal Pharmaceuticals
AMRX
$3B
| $94.7M | 1.43% | 11,710,332 +974,355 | +9% | +$7.88M |
|
19
Collegium Pharmaceutical
COLL
$1.22B
| $93.4M | 1.41% | 3,157,743 +157,743 | +5% | +$4.66M |
|
20
Integra LifeSciences
IART
$1.18B
| $90.2M | 1.36% | 7,353,934 +2,710,262 | +58% | +$33.3M |
|
21
Stratasys
SSYS
$906M
| $89.5M | 1.35% | 7,803,097 +1,205,764 | +18% | +$13.8M |
|
22
New Fortress Energy
NFE
$675M
| $81M | 1.22% | 24,400,000 +61,325 | +0.3% | +$204K |
|
|
23
Adaptive Biotechnologies
ADPT
$2.01B
| $72.9M | 1.1% | 6,256,847 -6,861,004 | -52% | -$79.9M |
|
24
Indivior
INDV
$3.03B
| $68.5M | 1.03% | 4,647,179 +1,117,140 | +32% | +$16.5M |
|
25
Opko Health
OPK
$1.1B
| $63.1M | 0.95% | 47,791,243 -915,397 | -2% | -$1.21M |
|